as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹383.05
Change
-3.45 (-0.89%)
Open
₹386.5
Prev. Close
₹386.5
Day High
₹386.95
Day Low
₹377.8
Volume Analysis
Traded
10,266
Delivered
7,636
Delivery %
74.38%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (0)
No signal for this stock
Opportunities (3)
- •Strong 3-year EPS growth (163.7%)
- •Strong 3-year revenue growth (202.5%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹396.55 | ₹391.75 | ₹387.4 | ₹382.6 | ₹378.25 | ₹373.45 | ₹369.1 |
| Fibonacci | ₹391.75 | ₹388.25 | ₹386.1 | ₹382.6 | ₹379.1 | ₹376.95 | ₹373.45 |
| Camarilla | ₹385.57 | ₹384.73 | ₹383.89 | ₹382.6 | ₹382.21 | ₹381.37 | ₹380.53 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-1.48%
1 Month
-2.67%
3 Months
-30.99%
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
42.74%
Net margin 14.06% × asset turnover 1.9x × equity multiplier 1.6x
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
One Global Service Prov L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 67/100. The strongest factor is Financial Strength (100/100), while Cash Flow (8/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising. Strong 3-year EPS growth (163.7%).
TopFund Score — Fundamentals Quality
67/100 — GoodData confidence: 72/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Cash Flow
Corporate Governance
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Completed acquisition of 51% each in Matrix Labs Diagnocare and Matrix Labs Private on 12 Nov 2026.
Please find attached intimation regarding newspaper publication of Postal Ballot under regulation 30 & 47 of SEBI (LODR), 2015
Postal ballot for CMD remuneration/reappointment, loan-to-equity conversion, and independent director appointment; voting from 6 Nov to 5 Dec 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 (S) | Dec 2023 (S) | Mar 2024 (S) | Jun 2024 (S) | Sep 2024 (S) | Dec 2024 (S) | Mar 2025 (S) | Jun 2025 (S) | Sep 2025 (S) | Dec 2025 (S) | Mar 2026 (S) | Jun 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 12 | 15 | 24 | 14 | 19 | 33 | 55 | 88 | 135 | 141 | 134 | 103 | 66 |
| Expenses + | 11 | 13 | 19 | 11 | 16 | 29 | 41 | 75 | 109 | 112 | 110 | 84 | 55 |
| Operating Profit | 1 | 2 | 5 | 2 | 3 | 5 | 15 | 13 | 26 | 29 | 24 | 19 | 11 |
| OPM % | 8.41% | 13.82% | 22.14% | 17.4% | 15.82% | 14.41% | 26.36% | 15.07% | 19.34% | 20.51% | 18.13% | 18.66% | 16.73% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 5 | 2 | 3 | 5 | 15 | 13 | 26 | 29 | 24 | 19 | 11 |
| Tax % | 25.0% | 25.13% | 25.56% | 24.57% | 25.08% | 27.04% | 24.71% | 25.04% | 25.01% | 25.12% | 25.26% | 25.01% | 24.64% |
| Net Profit + | 1 | 1 | 4 | 2 | 2 | 3 | 11 | 10 | 20 | 22 | 18 | 14 | 8 |
| EPS in Rs | 1 | 2 | 6 | 2 | 3 | 5 | 15 | 14 | 10 | 11 | 9 | 7 | 4 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 266 | 94 | 355 | 8 | 67 | 130 | 128 | 548 | 595 | 323 | 141 | 17 | -51 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 0 | 0 | 0 | 0 | 2 | 0 | 4 | 6 | 18 | 63 | 147 | 498 |
| Expenses + | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 16 | 53 | 122 | 405 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 10 | 25 | 93 |
| OPM % | — | — | — | 73.0% | 14.0% | — | 68.0% | 23.0% | 9.0% | 15.0% | 17.0% | 19.0% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 10 | 25 | 93 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3.0% | -1.0% | 25.0% | 26.0% | 25.0% |
| Net Profit + | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 7 | 18 | 70 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 2 | 10 | 26 | 36 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10.0% | 0.0% | 0.0% |
| Sales growth | — | — | — | — | 627 | -100 | — | 66 | 198 | 248 | 133 | 239 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | -5 | -5 | -5 | -5 | -4 | -5 | -2 | -1 | 0 | 7 | 52 | 122 | 144 |
| Borrowings + | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities + | 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 5 | 17 | 34 | 113 | 98 |
| Total Liabilities | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 254 | 262 |
| Fixed Assets + | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| CWIP | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Assets + | 0 | 0 | 0 | 2 | 1 | 0 | 3 | 5 | 9 | 28 | 104 | 252 | 260 |
| Total Assets | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 254 | 262 |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 20 | 20 | 20 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 14 | -11 |
| Cash from Investing Activity + | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | -11 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | -11 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 90 | 162 | 111 | -32 | 141 | 6 | 45 | 38 | 8 | 12 | 67 | 12 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Oct 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 70.49% | 62.52% | 55.24% | 55.53% | 69.97% | 69.98% | 28.31% | 26.16% | 26.14% | 23.87% | 23.86% | 27.11% |
| Promoters | 29.51% | 29.51% | 29.51% | 29.51% | 15.05% | 15.05% | 66.24% | 68.38% | 68.4% | 68.4% | 68.4% | 66.01% |
| FII | 0.0% | 7.97% | 15.26% | 14.98% | 14.98% | 14.98% | 5.44% | 5.45% | 5.44% | 7.72% | 7.72% | 6.86% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.01% | 0.01% | 0.01% | 0.01% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| One Global Service Prov L (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 451,075 | 36.7 | 5.05 | 16.0% |
| Divi S Laboratories Ltd | 294,139 | 86.1 | 16.34 | 16.5% |
| Torrent Pharmaceuticals L | 177,632 | 81.8 | 9.67 | 27.4% |
| Apollo Hospitals Enter. L | 125,893 | 55.6 | 11.86 | 21.5% |
| Laurus Labs Limited | 125,380 | 93.6 | 20.73 | 18.3% |
| Zydus Lifesciences Ltd | 118,693 | 26.2 | 4.27 | 21.2% |
Which Mutual Funds Hold One Global Service Prov L?
Frequently Asked Questions about One Global Service Prov L
One Global Service Prov L (ONEGLOBAL) closed at ₹383.05 on NSE on 19 November 2026, down 3.45 (0.89%) from the previous close.
One Global Service Prov L trades on the NSE (National Stock Exchange of India) under the symbol ONEGLOBAL.
One Global Service Prov L has a TopFund Quality Score of 67/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about One Global Service Prov L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.